
A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma
Keywords: ملفال; Myeloma; Allogeneic transplantation; Reduced-intensity conditioning; Fludarabine; Melphalan